Arthritis: all 3,555 studies

Page 9 of 36. Open to participants first (313), then studies with results posted, then the rest; newest registration first within each.

• RHYTHM (Formerly Escape II Myocardium)CompletedNCT01548768Phase 4Results posted
• A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA)CompletedNCT01544114Phase 4Results posted
• An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid ArthritisCompletedNCT01543503Results posted
• Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic ArthritisCompletedNCT01541917Phase 3Results posted
• The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid ArthritisTerminatedNCT01533714Phase 2Results posted
• A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)CompletedNCT01526057Phase 2Results posted
• Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α TherapyCompletedNCT01521884Results posted
• A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic ArthritisCompletedNCT01519089Phase 3Results posted
• AMG 827 in Subjects With Psoriatic ArthritisTerminatedNCT01516957Phase 2Results posted
• Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)CompletedNCT01513902Phase 1Results posted
• A Crossover Study of the Safety and Tolerability of Two Formulations of AdalimumabCompletedNCT01502423Phase 2Results posted
• Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic ArthritisCompletedNCT01500551Phase 2/3Results posted
• Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to MethotrexateCompletedNCT01500278Phase 4Results posted
• Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) TherapyCompletedNCT01490450Phase 2Results posted
• Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic ArthritisCompletedNCT01474876Results posted
• An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical PracticeCompletedNCT01474291Results posted
• β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)CompletedNCT01470989Phase 3Results posted
• Oral Baricitinib (LY3009104)Treatment in Japanese Participants With Active Rheumatoid Arthritis on Background Methotrexate TherapyCompletedNCT01469013Phase 2Results posted
• A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) TreatmentCompletedNCT01468077Phase 2Results posted
• A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in ChinaTerminatedNCT01464021Results posted
• A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid ArthritisCompletedNCT01462162Results posted
• Efficacy Confirmation Study of CDP870 in Early Rheumatoid ArthritisCompletedNCT01451203Phase 3Results posted
• Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid ArthritisCompletedNCT01443364Phase 4Results posted
• Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers SquibbCompletedNCT01439204Phase 1Results posted
• TIV and High Dose TIV in Subjects With Rheumatoid ArthritisCompletedNCT01436370Phase 2Results posted
• Correlation Between Beliefs About Medicine and Objective Measures of Efficacy and Safety in Rheumatoid Arthritis (RA)CompletedNCT01432366Results posted
• Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis PatientsCompletedNCT01431638Phase 3Results posted
• A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) PatientsCompletedNCT01426789Phase 2Results posted
• Treatment of Vitamin D Deficiency in Patients With Rheumatoid ArthritisCompletedNCT01426347Not applicableResults posted
• Extension Study Evaluating Etanercept in 3 Subtypes of Childhood ArthritisCompletedNCT01421069Phase 3Results posted
• Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing SpondylitisCompletedNCT01417455Results posted
• Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan)CompletedNCT01414257Results posted
• Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic ArthritisCompletedNCT01412021Results posted
• A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient DepartmentTerminatedNCT01411215Results posted
• Study of Two Different Starting Doses of Methotrexate When Starting Treatment in Rheumatoid ArthritisCompletedNCT01404429Phase 4Results posted
• Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA TrialCompletedNCT01400516Phase 4Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateCompletedNCT01399697Phase 4Results posted
• Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid ArthritisCompletedNCT01393639Phase 2Results posted
• Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)CompletedNCT01392326Phase 3Results posted
• A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002)TerminatedNCT01390441Phase 1Results posted
• A Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in MalaysiaCompletedNCT01387789Results posted
• Observational Study to Explore the Effectiveness of Adalimumab Treatment in Conjunction With Utilization of a Patient Support Program (PSP)CompletedNCT01383421Results posted
• A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid ArthritisCompletedNCT01382940Phase 4Results posted
• Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα AgentsCompletedNCT01377012Phase 3Results posted
• Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)CompletedNCT01374971Phase 3Results posted
• Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to MethotrexateCompletedNCT01373151Phase 2Results posted
• A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid ArthritisCompletedNCT01369745Phase 2Results posted
• Agility LP Ankle Arthroplasty OutcomesCompletedNCT01366872Results posted
• Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) TherapyCompletedNCT01362062Results posted
• Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking MethotrexateCompletedNCT01359943Phase 2Results posted
• A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or PlaceboCompletedNCT01359150Phase 2Results posted
• Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis PatientsCompletedNCT01356602Phase 3Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDsCompletedNCT01353859Phase 3Results posted
• Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) PatientsCompletedNCT01351480Phase 3Results posted
• Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1)CompletedNCT01350804Phase 3Results posted
• Special Investigation in Patients With Rheumatoid Arthritis (HOPEFUL III Study), a Follow-up Survey of Study P12-069CompletedNCT01346501Results posted
• Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)CompletedNCT01346488Results posted
• Supporting Decision Making for Musculoskeletal Preference-Sensitive CareCompletedNCT01345123Not applicableResults posted
• A Study of RoActemra/Actemra and, if Initially Inadequately Responded to RoActemra/Actemra, Followed by MabThera/Rituxan in Patients With Rheumatoid ArthritisCompletedNCT01332994Phase 3Results posted
• A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk FactorsCompletedNCT01331837Phase 4Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs or Anti-TNFCompletedNCT01326962Phase 3Results posted
• A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid ArthritisCompletedNCT01317797Phase 1Results posted
• Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab TreatmentCompletedNCT01316224Results posted
• A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)CompletedNCT01313858Results posted
• A Study to Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136)CompletedNCT01313520Phase 2Results posted
• Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)CompletedNCT01313208Phase 4Results posted
• An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB)CompletedNCT01309282Results posted
• Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)CompletedNCT01307423Phase 3Results posted
• Augment® Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot FusionsCompletedNCT01305356Not applicableResults posted
• Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid ArthritisCompletedNCT01299961Phase 3Results posted
• Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056TerminatedNCT01296711Phase 2Results posted
• Effects of Denosumab on the Pharmacokinetics of EtanerceptTerminatedNCT01294397Phase 1Results posted
• A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA)TerminatedNCT01292265Phase 3Results posted
• Periprosthetic Bone Mineral Density After Total Hip Arthroplasty Performed Through a Minimally Invasive Anterior Approach (AMIS) With Either an AMIStem or a Quadra Femoral ComponentCompletedNCT01285843Not applicableResults posted
• Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid ArthritisTerminatedNCT01285310Phase 2Results posted
• A Prospective Study to Evaluate the Effectiveness of a Haemostatic Agent in Primary Unilateral Total Hip ArthroplastyCompletedNCT01285024Not applicableResults posted
• A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-InhibitorTerminatedNCT01283971Phase 4Results posted
• Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With AdalimumabCompletedNCT01282372Results posted
• GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard TherapyCompletedNCT01274182Phase 1/2Results posted
• Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With AdalimumabCompletedNCT01273519Results posted
• A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior Anti-TNF Therapy (RESET)CompletedNCT01272908Phase 3Results posted
• Desflurane or Propofol Anesthesia in Elderly Obese Patients Undergoing Total Knee ReplacementCompletedNCT01270620Phase 4Results posted
• Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA)TerminatedNCT01264770Phase 2Results posted
• Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid ArthritisCompletedNCT01262118Phase 1Results posted
• Efficacy and Safety Dose Finding Study of Givinostat to Treat Polyarticular Course Juvenile Idiopathic ArthritisTerminatedNCT01261624Phase 2Results posted
• A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis SubjectsCompletedNCT01255761Phase 4Results posted
• An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local EnvironmentCompletedNCT01254331Phase 3Results posted
• A Study of Japanese Rheumatoid Arthritis ParticipantsCompletedNCT01253291Phase 1Results posted
• A Study in Rheumatoid ArthritisCompletedNCT01253265Phase 1Results posted
• A Study for Japanese Participants With Rheumatoid Arthritis (RA)CompletedNCT01253226Phase 1Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid ArthritisTerminatedNCT01251120Phase 4Results posted
• Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT01248780Phase 3Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT01245439Phase 3Results posted
• Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)TerminatedNCT01242514Phase 3Results posted
• Preoperative Alignment of Total Knee ReplacementCompletedNCT01242085Phase 3Results posted
• A Study of LY2439821 in Rheumatoid ArthritisCompletedNCT01236118Phase 1Results posted
• Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)CompletedNCT01235598Phase 3Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER)CompletedNCT01235507Phase 3Results posted
• A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT01232569Phase 3Results posted
• A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid ArthritisCompletedNCT01231321Phase 3Results posted

← Arthritis overview